Share This

Topics Comments

Cheung Kong VODone Limited Shenzhen International Holdings Limited Jiangxi Copper Company Limited REXLot Holdings Limited China Overseas Land & Investment Limited Chong Hing Bank Limited Agricultural Bank of China Limited Chow Tai Fook Jewellery Group Limited Capital VC Limited iShares A50 Standard Chartered Bank of Communications Bank of China China LotSynergy Holdings Limited agribank Agri Airlines Appl AUD Auto A Shares Brokers CAD fertilizer producers China Lottery Supermarket China Banks Communication Consumer China Econ Electricity China Finance China IT Petro Real Est China Resource Steel coal Commodity Beauty Drugs Enviro EURO Lang Simon Ting WongSir Andy Xie Expo Gambling Garment gas GBD Gold Gold Jew Gold mine Harbour Highways HK Apparel REITs Rentals HK Banks ETF HK Housing Market Real Est HK HK Stock iBond Infra Insure IPO jewel Mach Build Mat New Energy NZD Oil Paper Rare Earths Real Estate Market Food RMB Rising RMB RMB Bonds Shipbuilding Shipping Sports Stock Trend Taiwan Dollar (TWD) Textile Top 500 USD US Econ Util Water Yang Liu's 10 Stocks YEN Diary media Central Bank Monetary Policy Education Construction Emerging markets Nuclear power BillGross Cement HK retail logistics Swiss franc Social Security Fund Law Ka-Chung capital flow Financial and political policy Railway film Korean Won Roubini Faber Mobius
Topics Last reply time Nickname Content
TONG REN TANG TECHNOLOGIES CO., LTD. 2014-03-27T22:35 財經茄呢啡 藥材價格早出現強勁升浪,受天氣等因素影響產量減少,供應緊張,部份藥材價格漲幅逾50%。生產及銷售中成藥的同仁堂科技(1666)上周公佈2013年業績,銷售收入29.1億元人民幣,增長19%,淨利潤為3.9億元,上升18%。多隻中成藥股即將公佈業績,但在藥品生產質量及經營質量管理規範嚴厲實施下,中藥材價格一直高企,人工成本、運輸成本上漲。
TONG REN TANG TECHNOLOGIES CO., LTD. 2013-10-10T08:05 財經茄呢啡 同仁堂(1666)及子公司同仁堂國藥(8138)均有售的安宮牛黃丸,被廣東食品藥品監督管理局列入不合格藥品的藥業名單,因其豬去氧膽酸項目不合格。同仁堂國藥在中期報告表示,為滿足市場對安宮牛黃丸的需求,將繼續提升安宮牛黃丸的製造產能。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.